前列腺横纹肌肉瘤专家共识

参考文献/References:

1 Rudzinski ER,Anderson JR,Hawkins DS,et al.The World Health Organization classification of skeletal muscle tumors in pediatric rhabdomyosarcoma a report from the children’s oncology group[J].Arch Pathol Lab Med,2015,139(10):1281-1287.DOI:10.5858/arpa.2014-0475-OA.
2 PDQ Cancer Information Summaries[M].Bethesda(MD):National Cancer Institute (US),2002.
3 Dasgupta R,Rodeberg DA.Update on rhabdomyosarcoma[J].Semin Pediatr Surg,2012,21(1):68-78.DOI:10.1053/j.sempedsurg.2011.10.007.
4 Ries LAG,Harkins D,Krapcho M,et al.SEER Cancer Statistics Review,1975-2003,Bethesda,Md:National Cancer Institute; 2006.
5 Ferrer FA,Isakoff M,Koyle MA.Bladder/prostate rhabdomyosarcoma:Past,present and future[J].J Urol,2006,176(1):1283-1291.DOI:10.1016/j.juro.2006.06.019.
6 Skapek SX,Anderson J,Barr FG,et al.PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma:A children’s oncology group report[J].Pediatric Blood Cancer,2013,60(9):1411-1417.DOI:10.1002/pbc.24532.
7 Federico SM,Spunt SL,Krasin MJ,et al.Comparison of pet-ct and conventional imaging in staging pediatric rhabdomyosarcoma[J].Pediatr Blood Cancer,2013,60(7):1128-1134.DOI:10.1002/pbc.24430.
8 Campbell-Walsh Urology,11th edition.
9 Wu HY,Snyder HM 3rd,Womer RB.Genitourinary rhabdomyosarcoma:Which treatment,how much,and when?[J].J Pediatr Urol,2009,5(6):501-506.DOI:10.1016/j.jpurol.2009.06.011.
10 Wu HY,Snyder HM 3rd.Pediatric urologic oncology:bladder,prostate,testis[J].Urol Clin North Am,2004,31(3):619-627.DOI:10.1016/j.ucl.2004.04.004.
11 Hensle TW,Chang DT.Reconstructive surgery for children with pelvic rhabdomyosarcoma[J].Urol Clin North Am,2000,27(3):489-502.DOI:10.1016/s0094-0143(05)70096-3.
12 Saltzman AF,Cost NG.Current treatment of pediatric bladder and prostate rhabdomyosarcoma[J].Curr urol Rep,2018,19(1):1-9.DOI:10.1007/s11934-018-0761-8.
13 中国抗癌协会小儿肿瘤专业委员会,中华医学会儿科学分会血液学组,中华医学会小儿外科学分会肿瘤组.中国儿童及青少年横纹肌肉瘤诊疗建议(CCCG-RMS-2016)[J].中华儿科杂志,2017,55(10):724-728.DOI:10.3760/cma.j.issn.0578-1310.2017.10.002. Pediatric Oncology Committee of China Anti-Cancer Association,Hematology Section of Pediatrics Branch of Chinese Medical Association,Tumor Group of Pediatric Surgery Branch of Chinese Medical Association.Recommendations for diagnosis and treatment of rhabdomyosarcoma in children and adolescents in China (CCCG-RMS-2016)[J].Chinese Journal of Pediatrics Journal,2017,55(10):724-728.DOI:10.3760/cma.j.issn.0578-1310.2017.10.002.
14 Childhood Rhabdomyosarcoma Treatment (PDQ(R)):Health Professional Version[J].2018.
15 Joshi D,Anderson JR,Paidas C,et al.Age is an independent prognostic factor in rhabdomyosarcoma:a report from the soft tissue sarcoma committee of the children’s oncology group[J].Pediatr Blood Cancer,2004,42(1):64-73.DOI:10.1002/pbc.10441.
16 Malempati S,Rodeberg DA,Donaldson SS,et al.Rhabdomyosarcoma in infants younger than 1 year a report from the children’s oncology group[J].Cancer,2011,117(15):3493-3501.DOI:10.1002/cncr.25887.
17 Arndt C,Rodeberg D,Breitfeld PP,et al.Does bladder preservation (as a surgical principle) Lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from intergroup rhabdomyosarcoma study iv[J].J Urol,2004,171(6 Pt 1):2396-2403.DOI:10.1097/01.ju.0000127752.41749.a4.
18 Raney B,Anderson J,Jenney M,et al.Late effects in 164 patients with rhabdomyosarcoma of the bladder/prostate region:A report from the international workshop[J].J Urol,2006,176(5):2190-2194.DOI:10.1016/j.juro.2006.07.064.